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1. Introduction 
Osteoporosis (OP) is a serious disease and its early diagnosis is very important at the right 
time. These days, there are some conventional techniques of the diagnosis of this disease but 
these techniques have their limitations and reliable information is not obtained at the initial 
stage of the disease. Therefore, a new technique for the detection of OP at an early stage is 
required to be developed. In the present chapter, a new technique, based on Micro Electro 
Mechanical System (MEMS) technology, will be discussed to overcome the limitations of 
earlier techniques.  
In the present chapter, main emphasis is placed on the early detection of OP. New types of 
OP detection techniques, based on the biomechanical, optical and electrochemical principles, 
will be explained and compared to achieve an improved detection methodology for OP. A 
new amperometric immunosensor using gold nanoparticles and a novel microfluidics 
BioMEMS chip as a point of care testing (POCT) technique will be introduced for design, 
fabrication and characterization. 
The chapter covers the study which has been mainly divided into three parts: basic 
measurements on physical, biomechanical, optical and chemical properties of normal and 
OP bones and serum; and design and development of amperometric immunosensor and 
BioMEMS chip. (Ahn C.H et al., 2004, Arnaud C.D at al., 1996 Atkinson, P.J.  1964, Auroux, 
P.A et al., 2002, Bakker, E., 2006,  Berthonnaud L, F., 2002, Bianchi, 2005, Ban C, 2004, Bal 
S.K, 2002) 
An overview of OP research trends with the objectives of the research, and scope and 
significance of the study, is also presented. Causes and diagnostic techniques for OP will be 
reviewed in the beginning of the chapter.  
2. OP detection & early detection of osteoporosis (EDO) 
Since OP is most common among elder people, the overall costs to maintain the healthy 
body will most likely escalate in the near future. Hence to reduce the sufferings, the best 
solution is early detection (Bianchi, M.L., 2000, Blair, 2000). The early detection of disease 
states results in improved treatment outcomes, possibility of living longer a healthy life 
(Arnaud et al., 1996; Singh, 2006).  
Early detection is possible by biomarkers or the "intervening phenotypes" in the biofluids like 
saliva, serum and urine which can be (a) surrogate measures of any malignancy in the bone; 
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(b) identifiers of inherited variations associated with disease susceptibility; or (c) "pre-disease" 
lesions that are highly predictive of subsequent disease(Becerra-Rojas & Jupari, 2001). 
Diagnosis of OP at the right time can save from compressive treatments and immobility. 
Generally, in medical practice, identification of disease is based on recognition of symptoms 
and also testing specific features to confirm the presence of a particular disease. But for OP, 
it is hard to predict the disease as it silently creeps into the body with minimal symptoms of 
back pain, toothache and some hunch-over, etc. These initial symptoms point to the old age 
also and hence the unaware patient realizes this only after having a fracture in the bone. The 
unaware human when realizes about the disease due to some bone-fractures. In the hospital, 
anteroposterior and lateral X-rays of the special bone site are obtained to assess the presence 
of fractures, using the BMD measurements. Finally, they realize the presence of OP then the 
treatment becomes unaffordable and the patient becomes bed-ridden as shown in Fig. 2. 
Hence early detection of OP (EDO) is extremely necessary (see Table 1) with new devices 
like POCT (point of care technology) device using BioMEMS technology. Micro-fluidic chips 
are also playing key role to deliver new devices for better health care. The sensitivity and 
specificity of the POCT device would give earliest possible detection. Several promising 
directions for detection of bonemarker for OP have been interrogated (Arnaud, 1996; Singh, 
2006, Singh, 2007, Singh, 2008, Singh, 2009).  
Various researchers have studied OP disease for biological, chemically, physiological and 
engineering aspects in the past, by using different types of measurement techniques and 
methodologies (Arnaud, 1996; Korkia, 2002; Raiz, 1997; Singh, 2006). However, newer and 
newer techniques with new advances in technology, like micro/ nano technology, are being 
developed. 
 
 
Fig. 1. Early Detection of OP (EDO) 
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S.No Specification Consequences
1 Early detection Screening for large number of population 
2 Minimal invasive Uses only micro amounts of biofluids 
3 Site-specific Bone turnover specific bonemarkers 
4 Diagnostics levels OP-specific
5 User-friendly Self testing is possible, easy to use 
6 Simple, low cost Portable, home care
Table 1. Importance of EDO(Singh, 2006) 
3. Technical terminologies 
3.1 Osteoproteogerin 
Osteoprotegerin, also known as osteoclastogenesis inhibitory factor (OCIF), is a cytokine 
and a member of the tumor necrosis factor (TNF) receptor superfamily. It is a basic 
glycoprotein comprising 401 amino acid residues arranged into 7 structural domains. It is 
found as either a 60 kDa monomer or 120 kDa dimer linked by disulfide bonds. 
3.2 Biological MEMS (BioMEMS) 
It is a combination of a Micro-electromechanical system (MEMS) with the biological 
systems, like protein, DNA or cell. It includes micro- and nanosystems for genomics, 
proteomics, and drug delivery analysis; molecular assembly, tissue engineering, biosensor 
development, and nanoscale imaging (Singh et al., 2007, 2009, Vijayendran et al., 2003). 
3.3 Microfluidics  
Microfluidics is a multidisciplinary field comprising physics, chemistry, engineering and 
biotechnology that studies the behavior of fluids at the microscale and mesoscale, that is, fluids 
at volumes thousands of times smaller than a common droplet. It also concerns the design of 
systems in which such small volumes of fluids are used (Singh, 2007; Vijayendran et al., 2003). 
3.4 Electrochemical sensor  
The biosensor in which a biological process is harnessed to an electrical sensor system, such as 
an enzyme electrode. Other types couple a biological event to an electrical one via a range of 
mechanisms, such as those based on oxygen and pH (Heineman, 2001, Singh et al, 2008, 2009). 
3.5 Immunosensor  
Immunosensor uses the immuno-compounds (antibodies or antigens) as biological receptors 
configures the so-called immunosensors, which are usually the result of the integration in 
one device of an immunoassay and a directly associated transducer. The antigen-antibody 
complex formation can be detected either directly (without using any labeled compound) by 
certain physical (potential, capacitance, conductivity compound) measurements or indirect 
approaches in which one immuno-compound is conjugated with an indicator molecule 
(Bakker and Quin, 2006). 
3.6 Spectroscopy  
It is a non-invasive analytical technique with an infinitely broad range of applications, 
especially in medical field. This gives a non-destructive analysis. It helps in identification of 
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the elements and the elucidation of atomic and molecular structure by measurement of the 
radiant energy absorbed or emitted by a substance in any of the wavelengths of the 
electromagnetic spectrum in response to excitation by an external energy source (Chittur, 
1998; Clark and Hester. 1996). 
3.7 Lab-on-a-chip (LOC) 
LOC is to integrate multiple functions on a single chip of only millimeters to a square 
centimeters in size and that are capable of handling extremely small fluid volumes down 
less than pico liters, LOC device is a sub-set of MEMS device (Chittur, 1998; Clark and 
Hester, 1996). The term "Lab-on-a-Chip" was introduced later on when it turned out that 
µTAS (Micro Total Analysis System) technologies were more widely applicable than only 
for analysis purposes. 
(http://en.wikipedia.org/wiki/Lab-on-a-chip). 
4. Classification of OP detection techniques 
There are several methods for detection of OP as shown in Fig. 2 (Singh, 2006). 
 
 
Fig. 2. Classification of Detection Techniques for OP (Singh, 2006) 
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4.1 Radiographic diagnosis   
Radiogrammetry, a technique that has been in use for more than 30 years, relies on the 
measurement of the cortical thickness of bones in the hand (metacarpals) to estimate bone 
mass. This technique suffers from relatively poor accuracy and reliability and has largely 
been supplanted with new techniques(Bianchi, 2000) 
The following diagnostic techniques are generally used for the detection of osteoporosis 
(Arnaud, 1996; Sartoris, 1996, Bianchi, 2005) 
Bone Mineral Density Technique (BMD) is an effective approach for detection of 
osteoporosis. A decrease in the amount of bone, resulting in thin, weakened bones that are 
susceptible to fractures. Several techniques are available for BMD testing. For example; 
dual-energy X-RAY absorptiometry (DXA) remains the standard for testing the BMD. Dual 
energy absorptiometry measures the bone density within a given area of bone (g/cm2). This 
technique offers the advantages of higher precision, minimal ionizing radiation exposure, 
rapid scanning time and the ability to access cortical and trabecular bone mass at 
appendicular and axial sites. Limitation, include equipment expense, the need for certified 
X-Ray technician and non-portability. In addition, DXA scans of the spine may show a false 
increase in spinal BMD in patients with osteophyes, aortic calcifications and degenerative 
arthritic changes.  
The conception of osteoporosis relates bone health to bone strength, rather than mass. A 
bone’s health implies that it should have enough strength to keep voluntary loads from 
causing spontaneous fractures. Thus, the diagnosis of osteoporosis would be a 
biomechanical matter concerning both bone strength and muscle strength (Martin et al., 
1998). This supposes two kinds of problems, namely: (a) to properly assess bone material 
properties, structural design and strength; and (b) to correlate the respective indicators with 
suitable indicators of muscle strength. As a standard densitometry is unsuitable to assess 
muscle strength or bone strength, it should use of other, preferably cross-sectional analyses 
of bone structure as those provided by quantitative computed tomography (QCT), 
peripheral quantitative computed tomography (pQCT), MRI, or similar procedures. The 
value of pQCT lies in the ability of the software to account for all the `mass’, material and 
architectural factors in whose-bone strength and to provide data on muscle cross-sections 
(Burr, 1997, Boyle et al, 2003, Singh et al, 2006). 
4.2 Quantitative CT 
This provides the evaluation of trabecular bone density of the lumbar spine based on bone 
volume. Quantitative computed tomography (QCT) may be less practical than DXA because 
of the lower precision, higher cost and increased radiation exposure (Singh et al, 2006).   
4.3 Peripheral bone densitometry  
These devices used for many devices single-energy X-ray absorptiometry, peripheral DXA 
and peripheral CT. these device have the advantages of less expense, portable equipment, 
reasonable precision, and low radiation exposure. The use of quantitative ultrasonography 
for screening of osteoporosis and assessing fracture risk has increased. Using the speed of 
sound and broadband ultrasonic attenuation measurements, ultrasonic densitometry 
provides on bone elasticity and structure in peripheral sites. Advantages of this method, is 
low cost and lack of ionization radiation (Singh et al, 1997, 1998, 1999, 2006).  
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4.4 Single-energy absorptiometry  
Single-energy absorptiometry measures bone mineral at peripheral sites such as the wrist 
and heel. Single photon absorptiometry (SPA) used a radioactive energy source, usually 
iodine125 to estimate the amount of bone mineral at peripheral measurement sites. In recent 
years, Single-energy X-ray absorptiometry (SXA) has supplanted SPA for measurements of 
the peripheral skeleton (heel and wrist) because of its better reproducibility and ease of use. 
SXA avoids the necessity of obtaining and disposing of radioactive energy sources.  It 
requires immersion of the part in water bath and hence can measure bone mass in 
peripheral bones like bones of forearm and legs (Singh et al, 2006, Blair et al, 2003). 
4.5 Dual-energy absorptiometry  
Bone density tests are painless, non-invasive and safe. Dual-energy absorptiometry was 
developed to measure bone in parts of the skeleton (lumbar spine, hip, and total body) that 
could not be measured with single-energy devices. Currently dual-energy X-ray 
absorptiometry (DXA) is the most widely used technique for measuring bone at these sites. 
DXA devices also are capable of measuring bone at the heel and wrist with high accuracy 
and precision, with very low exposure to radiation (Singh et al, 2006).   
4.6 Peripheral quantitative CT (pQCT)  
Quantitative computed tomography (QCT) measures the density of vertebral trabecular 
bone, the spongy bone in the center of the vertebra. pQCT devices are QCT instruments that 
have been adapted for measurements at peripheral sites such as the wrist (Singh et al, 2006).  
4.7 Quantitative ultrasound (QUS) 
Quantitative ultrasound devices measure bone at several skeletal sites, including the heel, 
hand, finger, and lower leg. The heel measurement it is composed of primarily trabecular 
bone, similar to the composition of the spine. Ultrasound devices based on the changes in the 
speed of sound (SOS), as well as specific changes in sound waves (broadband attenuation or 
BUA) as they pass through bone. QUS measurements provide information on fracture risk by 
providing an indication of bone density and possibly also information on the quality of the 
bone. Ultrasound devices do not expose the patient to ionizing radiation. Ultrasound devices 
do not expose the patient to ionizing radiation (Singh, 2006, Sartris, 1996) 
4.8 Digital X-ray radiogrammetry (DXR) 
Recently, the computer technology has renewed interest in this old technique. The Pronosco 
X-posure system estimates forearm bone mass from measurements of the cortical width of 
bones in the hand using computerized digital x-ray radiogrammetry from a single plain 
radiograph of the hand and wrist. The BMD estimate, referred to as DXR-BMD, is corrected 
for cortical porosity and striation. The results indicate that this technique is highly 
reproducible and appears to be at least as good as other peripheral bone assessment 
techniques in its ability to discriminate among patients with low bone mass at the spine 
and/or hip and osteoporotic fractures (Sartoris, 1996).  
4.9 Photodensitometry  
Previously, radiographic absorptiometry (RA) uses standard X-ray images of the hand and 
distal forearm are taken with a graduated aluminum reference. The radiographic image of 
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the hand and wrist is captured by a video camera and the levels of grey seen on the hand 
image are quantified and compared with the grey levels of the reference standard, resulting 
in an estimate of bone mineral density (BMD). The cortical thickness of the bones can also be 
measured. Radiographic photo densitometry comprises of comparing the optical density of 
bone X-ray with standard calibrative, aluminium-step-wedge. Although inexpensive and 
easily accessible, this method had poor reproducibility. Computer-assisted methods have 
reduced these errors and several commercial systems have been developed in recent years. 
Although RA is generally less precise than DEXA, radiographic absorptiometry holds 
promise as a cost-effective method to screen cases of osteoporosis. Further research is 
needed to evaluate its effectiveness in predicting fracture and monitoring therapy (Sartoris, 
1996, Singh et al, 2006, Blair et al, 2006, Bouxsien and Mary, 2005).   
4.10 Double photon absorptiometry  
The principle of dual photon absorptiometry (DPA) is the use of a photon beam that has two 
distinct energy peaks. One energy peak will be more absorbed by soft tissue and the other 
by bone. The soft tissue component then can be mathematically subtracted and the BMD 
thus determined (Sartoris, 1996). 
4.11 Neutron activation analysis  
A limb is bombarded by slow neutron from a generator. This is taken up by the soft tissue 
to convert it into thermal neutron. This thermal neutron is captured by the nucleus of 
calcium ion. The nucleus becomes radioactive. Decay of the nuclei emits photon which 
can be measured by a Geiger counter, giving an idea of bone mass. This is reduced in 
osteoporosis.  
(source: www.iupac.org/publications/pac/1995/pdf/6711x1929.pdf). 
4.12 Biochemical techniques 
Biomarkers are substances found in an increased amount in the blood, other body fluids, or 
tissues and which can be used to indicate the presence the presence of osteoporosis. 
Biomarkers of bone remodeling (formation and breakdown), such as alkaline phosphatase 
and osteocalcin (serum markers) and pyridinolines and deoxypyridinolines (urinary 
markers), help in evaluating risk for osteoporosis. The research studies show that 
biomarkers correlate with changes in indices of bone remodeling and may provide insights 
into the mechanisms of bone loss which may give a basic detection method. The method 
may not be precise or accurate but it is quick, early, cheap and non-invasive way of 
detection. This method gives an indication of the onset of the disease (Sia, 2003). 
4.13 Bone markers 
There is a need for the development a non-invasive and repeated measurement of bone 
turnover which demands precision, accuracy and specificity. These kind of independent 
measurements of bone formation and resorption are done at organ or tissue level. The 
validated biochemical markers are urine and serum (see Table 2). 
The two main biochemical markers for bone formation are serum alkaline phosphatase and 
serum osteocalcin. Markers for bone resorbtion include urinary calcium and urinary 
hydroxyproline: Alkaline phosphatase, which reflects osteoclast activity in bone, is 
measured in serum, but it lacks sensitivity and specificity for osteoporosis, because it can be 
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elevated or decreased with many diseases. It is increased with aging (see Table 2). Urinary 
calcium can give some estimate of resorbtion (loss of) bone, but there are many variables 
that affect this measurement. Urinary hydroxyproline is derived from degradation of 
collagen, which forms extracellular bone matrix. However, hydroxyproline measurement is 
not specific for bone, because half of the body's collagen is outside the bony skeleton. It is 
also influenced by many diseases, as well as diet. Several ELISA kits are developed by 
Osteomark Company for detection of Osteoporosis (www.osteomark.org). 
 
S.No Osteoblastic Activity Osteoclastic Activity 
1 S-alkaline phosphatase 
- Total alkaline phosphatase (S-tAP) 
- Bone alkaline phosphotase (S-bAP) 
U-Hydroxyproline(U-OHPr) 
2 S-osteocalcin(S-BGP) U-collagen crosslinks 
- Pyridinoline(U-Pyr) 
- Deoxypryridine(U-D-Pyr) 
3 S-carboxyterminal propeptide of human 
type I collagen(S-PICP) 
S-C Terminal pyridine crosslinked 
telopeptide domain of type I  
collagen (S-ICTP) 
S-Tartrate-resistant acid  
phosphatase(S-TRAP) 
Table 2. Urine and serum markers (Sartoris, 1996) 
4.14 Laboratory methods   
There are several preliminary tests to identify the loss of bone mass. A number of laboratory 
tests may be performed on blood and urine samples (Singh et al, 2006).   
The most common blood tests evaluate: 
 blood calcium levels 
 blood vitamin D levels 
 thyroid function 
 parathyroid hormone levels 
 estradiol levels to measure estrogen (in women) 
 follicle stimulating hormone (FSH) test to establish menopause status 
 testosterone levels (in men) 
 osteocalcin levels to measure bone formation. 
4.15 Needle bone biopsy  
Needle bone biopsy is not a very common assessment technique of bone density. This test 
has limited availability, and is best utilized as a research technique for analysis of treatment 
regimens for bone diseases. The best clinical use of bone biopsy combines double 
tetracycline labeling to determine appositional bone growth and rule out osteomalacia. 
Doses of tetracycline are given weeks apart, and the bone biopsy is embedded in a plastic 
compound, sliced thinly, and examined under fluorescent light, where the lines of 
tetracycline (which auto fluoresce) will appear and appositional growth assessed (Singh et 
al, 2006).  
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5. Recent novel techniques  
Osteoporosis is the disease which creeps into one’s body silently without showing a 
significant symptom. The nature of the disease asymptotic until a gross deformity occurs in 
one’s body. This is can be very serious and deadly for the patient. The time the patient 
realizes structural support of the body has totally deteriorated. The diagnosis and treatment 
is sometimes unaffordable for a common man. The patient has the control over prevention 
of this disease or is reliable, easy and cheap way is available for such deadly disease than 
proper care can be taken. There are several researches going on in order to achieve some 
cheap, easy early detection of osteoporosis (Singh et al, 2006). The latest trend is in 
miniaturizing the device which make it portable, useful for homecare, user-friendly, cheap, 
Non-invasive and provides a kind early indication for OP. This technique is based on MEMS 
based technique. 
5.1 Bone fracture detection micro-sensor  
The method for detection or investigation of osteoporosis is with the help of a micropump 
(Yung et al, 2004). The micropump has been designed using the electromagnetic principle to 
actuate the piston in two directions. A closed loop system is used for circulating the fluid 
with the pumping device. This is kind of pump is useful for blood sampling or drug 
delivery. Here the oscillating micropump is used to study the mechanosensitivity of bone 
cell for better investigation of osteoporosis. There is another research which has proposed an 
implantable, telemetry-based MEMS bone sensor (Singh et al, 2003, 2009) with the capability 
of determination of bone stress via wireless RF interface. The bone stress is detected using 
the embedded piezoresistive strain gauges with polysilicon layer and a CMOS chip (Singh, 
1997). 
Another design of micro-fabricated strain gauge array is used to monitor bone deformation 
in vitro and in vivo for detection of osteoporosis. These kinds of microsensor provide a map 
of distributed strain data over the area of interest on the surfaces of bone to monitor the 
structural integrity of bone. This type of strain membranes are wireless and implantable 
embedded in flexible membrane. A simulation experiment was conducted to develop such 
micro-strain gauge for study of osteoporotic bone (Yang et al, 2004). 
A bone sensor has been used for the piezoelectric BioMEMS. An attempt has been made to 
develop bone-based piezoelectric sensors to detect the stress in bone (Singh, 2003). 
Another micro-scale sensor for bone surface strain measurement is discussed. This kind of 
sensor is used for studying the structural effects of osteoporosis. Designs and simulation 
using ANSYS finite element modeling tool of thin-film metal strain gauge. Metal films for 
electrical interconnection encapsulated in PDMS have been studied. The PDMS membrane 
was characterized to facilitate encapsulation designs. The basic fabrication steps like 
silanization, PDMS preparation, photolithography, PDMS metallization, wire bonding 
and finally device separation. With experiments were performed for optimizing  
and characterizing the device like mechanical testing, electrochemical testing and  
adhesion testing (Yang et al, 2004), and there is a new design which has been discussed 
here. 
Another latest technology is detecting osteoporosis with the study of the brittleness of the 
bone. The bone mass and bone density play an important role in bone strength. It is 
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important to measure the brittleness or fragility or the bone mechanics. Certain walking 
studies are done and it is found that as the heel strikes the ground it creates force pulse, 
energy that passes up through the body and it is absorbed by bone. The osteoporosis 
reduces the quality of the bone so by attaching the skin-mounted sensors for measuring the 
electrical pulses of the muscles which is an active part of the skeletal system. If the person 
has osteoporosis the energy which passes up to the body is disrupted due to porous nature 
of the bone (http://www.uc.edu/news/NR.asp?id=3280). 
5.2 Microfluidic channels – Detection by biomarkers 
The total Alkaline phosphatase (AP) is the mostly widely used bone marker in the clinics 
and hospitals. AP have physiological substrates which splits the inorganic phosphatase 
with organic phosphatase, increasing the calcium-phosphatase product and enabling 
mineralization. AP is essential for normal mineralization of the bone. Bone AP (bAP) 
constitutes approximately 50% serum AP and the serum has the half-life of 24-48hrs. 
Though the half-life is relatively large but it may differ on cardiac rhythm, with peak 
levels in afternoon and night. The exact metabolic pathway is unknown. AP is measured 
with the help of spectrophotometer using p-nitrophenylphosphate as substrate. The bone 
and liver AP may be separated by electrophoresis but this method is time consuming and 
gives semi-quatitaive results. The concentration of bAP concentration may be measured 
using two antibodies with small differences in affinity toward the isoforms (Singh et al, 
2006).  
MEMS based detection with alkaline phosphatase has been attempted by Kang and Park 
(2005). A microfluidic device has been used for enzyme assay. The measurement of enzyme-
substrate reaction will to do the substrate consumed. A lab-on-a-chip (LOC) device is 
developed for controlling the flow containing small volumes of liquids in microchannel 
which can speeed up and simplifies sample preparation steps in LOC which offers high 
throughput, low version of traditional research. The microfluidic device is fabricated by the 
casting process with PDMS. It consists of three parts part I is the injection system, part II is 
the reaction chamber and part III is the microchannel. This particular microchannel 
measures the ALP activity using a micro-plate reader. Microfluidic mixing for single 
enzyme assay was applied and with mathematical prediction the enzymatic (Singh et al, 
2006). 
5.3 Biochemical based BioMEMS chip 
A novel BioMEMS chip, based on gold nanoparticles, for the detection of osteoproteogerin 
(OPG). This biochip is used to evaluate the bone conditioning which is directly related to the 
diagnosis and prognosis of the osteoporosis, in an effective manner. The flow visualization 
of the mixing capabilities are characterized using micro-scale laser-induced fluorescence 
(LIF). The BioMEMS chip detection is based on competitive immunoassay. The monoclonal 
OPG antibody (anti-OPG) is immobilized onto the AuNPs deposited conducting polymer, 
using covalent bonding with a carboxylic acid group. The catalytic reduction is monitored 
amperometrically at - 0.4 V versus Ag/AgCl. The linear dynamic range is between 2 to 24 
ng/ml with the detection limit of 2 ng/ml (Singh et al., 2007). Fig. 3 depicts schematic of the 
microfluidic chip. 
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Fig. 3. Microfluidic technique for early detection of OP(Singh et al., 2007 & 2009) 
 
Bone Formation Bone Resorption 
 Osteocalcin (OC) 
 Bone-specific alkaline phosphatase 
(BAP) 
 Amino terminal propeptide of type  
I collagen (PINP)  
 Carboxy terminal propeptide of type  
I collagen (PICP) 
 Pyridinoline (Pyr) 
 Deoxypyridinoline (dPyr) 
 Amino terminal telopeptide of type  
I collagen (NTx) 
 Carboxy terminal telopeptide of type  
I collagen (CTx) 
Table 3. Biochemical Indices (Singh et al., 2006) 
(http://www.scielo.br/img/revistas/abem/v50n4/31869t2.gif) 
5.4 BioMEMS-based sensors 
BioMEMS using electrochemical immunoassay with microfluidic system (Heineman et al, 
2001) help in blood sample analysis using the heterogeneous immunoassay. Two concepts of 
immunoassay are studied in this research. First is based on analogous microcapillary 
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immunoreactor and other combines the reaction and detection chamber within the area of 
electromagnet. Both are MEMS based system for alkaline phosphatase study. 
Another MEMS microvalve with PDMS diaphragm and two chambers with thermo-
pneumatic actuator for integrated blood test system with silicon have been suggested for 
point of care device. The blood test system can be reduced to reasonable cost with MEMS 
technology (Singh, 2006). The microvalve with long stroke has been fabricated with two 
chamber thermo-pneumatic actuator. 
5.5 Spectroscopic techniques for early detection of OP 
Optical techniques such as Fourier Transform Infrared Spectroscopy (FTIR) and Ultra Violet 
Visible Spectroscopy (UV-Vis) are employed to find the bone markers with an emphasis on 
the noninvasive modalities for early detection of osteoporosis. Blood plasma samples 
procured from two groups, patients and healthy persons were tested. Both of the optical 
techniques revealed obvious differences in the spectra; between two groups, for example, 
increase in intensity for OP persons. New peaks were found at 1588, 1456 and 1033 cm-1 in 
FTIR spectra, as shown in Fig. 4. On the other hand, in UV-Visible spectroscopy results, a 
new peak appeared in the OP patients’ spectra at the wavelength of 420 nm, as shown in 
Fig. 5. These differences in the spectra of the two types of samples, allow rapid and cost-
effective discrimination of the potential patients with the optical techniques which were 
verified by the bone densitometer in the hospitals. The new technique used here is quick, 
reliable and effective.  
A hierarchical algorithm is used to investigate and quantify the mutual relevance between 
successive clusters in terms of heterogeneity values as shown in the Fig.6. 
Fig. 6 represents the classification with the spectra at 1539-1542 cm-1. This gives clear 
distinction between the patients and healthy groups for the amide II group. 
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Fig. 4. FTIR results for EDO (Singh et al., 2010) 
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Fig. 5. UV-visible spectroscopy for EDO (Singh et al.,2010) 
 
   
 
 
Fig. 6. Cluster analysis(Singh, 2010) 
6. Discussions 
6.1 Bone density testing  
There is several bone density measurement testing techniques which have been discussed with 
their working principles. The recent developments in the instruments for BMD measurement 
have also been discussed. But there are several limitations in these devices. The testing with 
these devices is very expensive, early detection is not easy, these are invasive measurement, 
errors in magnification may occur, accuracy is not achievable, scan time is high, harmful 
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radiation may cause problems in the body, home care is not possible and the instruments are 
not portable. Specially trained persons are required to operate such sophisticated equipments. 
Though BMD measurement is the most accurate method for detection of Osteoporosis but it is 
unable to help in early detection and is very expensive. Early detection of such a silent and 
deadly disease is important for the mankind. Hence there is a need for new, novel, portable, 
cheap detection systems to be developed for point of care testing.  
6.2 Invasive technique 
The invasive technique has several risks involved like skin is punctured. There is a slight 
chance that the needle may cause fracture the bone being sampled or injure one of the 
nerves, blood vessels, or organs near the biopsy site. If complications occur, another surgery 
may be needed to treat the problem. After a bone biopsy, there is a slight chance that the 
bone may become infected, osteomyelitis or not heal properly. In rare instances, the bone 
from which the biopsy sample was taken may become weak and break, fracture at a later 
time. This type detection is only good for extreme severe cases. 
6.3 Biochemical measurement  
There are several bone markers or the biomarkers available for the early detection of the 
osteoporosis which control the osteoblastic and osteoclastic activity. The biochemical detection 
is not accurate detection but it gives the indication for onset of osteoporosis detection.  
6.4 MEMS-based techniques 
The MEMS-based techniques are portable, handheld, easy to use, can be used for home care 
and point-of-care testing. But the accuracy of the detection may be achieved by using bone 
mineral density testing (BMD) (Singh et al., 2009, 2010). 
7. Conclusions 
The radiographic techniques are needed for the accurate detection of osteoporosis as they 
give precise data for detection of the deadly disease. Generally, the patients are just unaware 
of the disease as osteoporosis creeps silently within a human body. Osteoporosis is a silent 
killer and is a very progressive disease. The time the person realizes the detection and 
treatment becomes unaffordable for patient. This research paper focuses on the urgent need 
for the development on early, non-invasive, cheap, and handheld POCT device for such a 
dangerous disease. These characteristics can be achieved by using a micro-size (MEMS/ 
Nano based techniques). There have been several attempts in this direction as mentioned in 
the paper above. But this area needs more of research and deep studies. 
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